| Recruitment status | Preinitiation |
| Unique ID issued by UMIN | UMIN000026688 |
| Receipt No. | R000030642 |
| Official scientific title of the study | Effect of dexmedetomidine in the prophylactic endoscopic injection sclerotherapy for esophageal varices: A study protocol for prospective interventional study |
| Date of disclosure of the study information | 2017/03/25 |
| Last modified on | 2017/08/03 (Ver. 2) |
| Basic information | ||
| Official scientific title of the study | Effect of dexmedetomidine in the prophylactic endoscopic injection sclerotherapy for esophageal varices: A study protocol for prospective interventional study | |
| Title of the study (Brief title) | Effect of dexmedetomidine in the prophylactic endoscopic injection sclerotherapy for esophageal varices: A study protocol for prospective interventional study | |
| Region |
|
|
| Condition | |||
| Condition | Esophageal varices | ||
| Classification by specialty |
|
||
| Classification by malignancy | Others | ||
| Genomic information | NO | ||
| Objectives | |
| Narrative objectives1 | The aims of the current study are to prospectively examine the safety and usefulness of DEX on sedation during prophylactic EIS for patients with EVs. |
| Basic objectives2 | Safety,Efficacy |
| Basic objectives -Others | |
| Trial characteristics_1 | |
| Trial characteristics_2 | |
| Developmental phase | |
| Assessment | |
| Primary outcomes | (a)Decreasing rate in SpO2 during endoscopic procedures
(b)Increasing or decreasing rates in blood pressure during endoscopic procedures (c)Pulse fluctuation during endoscopic procedures (d)The rate of complications including disturbance or others (e)Ramsey Sedation Scale values |
| Key secondary outcomes | |
| Base | |
| Study type | Interventional |
| Study design | |
| Basic design | Single arm |
| Randomization | Non-randomized |
| Randomization unit | |
| Blinding | Open -no one is blinded |
| Control | Self control |
| Stratification | |
| Dynamic allocation | |
| Institution consideration | |
| Blocking | |
| Concealment | |
| Intervention | ||
| No. of arms | 1 | |
| Purpose of intervention | Treatment | |
| Type of intervention |
|
|
| Interventions/Control_1 | The aims of the current study are to prospectively examine the safety and usefulness of DEX on sedation during prophylactic EIS for patients with EVs as compared with midazolam. | |
| Interventions/Control_2 | ||
| Interventions/Control_3 | ||
| Interventions/Control_4 | ||
| Interventions/Control_5 | ||
| Interventions/Control_6 | ||
| Interventions/Control_7 | ||
| Interventions/Control_8 | ||
| Interventions/Control_9 | ||
| Interventions/Control_10 | ||
| Eligibility | ||||
| Age-lower limit |
|
|||
| Age-upper limit |
|
|||
| Gender | Male and Female | |||
| Key inclusion criteria | 1.Patients with liver cirrhosis (LC) (diagnosed by liver histology or radiologic findings) who will require prophylactic EIS for EVs. Presence or absence of past history for endoscopic treatments for EVs is not required. Causes of LC are not also limited.
2. Child 5 or 6 or 7 points. |
|||
| Key exclusion criteria | Exclusion criteria
1.Poor liver function (Child-Pugh points of 8 or more) 2.Patients with severe comorbid diseases 3.Patients who were judged to be inappropriate for the study subjects |
|||
| Target sample size | 50 | |||
| Research contact person | |
| Name of lead principal investigator | Shuhei Nishiguchi |
| Organization | Hyogo college of medicine |
| Division name | Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine |
| Address | 1-1, Mukogawacho, Nishinomiyashi, Hyogo, 663-8501, Japan. |
| TEL | 0798-45-6472 |
| nishiguc@hyo-med.ac.jp | |
| Public contact | |
| Name of contact person | Yoshinori Iwata |
| Organization | Hyogo college of medicine |
| Division name | Division of Hepatobiliary and Pancreatic disease, Department of Internal Medicine |
| Address | 1-1, Mukogawacho, Nishinomiyashi, Hyogo, 663-8501, Japan. |
| TEL | 0798-45-6472 |
| Homepage URL | |
| yo-iwata@hyo-med.ac.jp | |
| Sponsor | |
| Institute | Hyogo college of medicine |
| Institute | |
| Department | |
| Funding Source | |
| Organization | Hyogo college of medicine |
| Organization | |
| Division | |
| Category of Funding Organization | Self funding |
| Nationality of Funding Organization | |
| Other related organizations | |
| Co-sponsor | |
| Name of secondary funder(s) | |
| Secondary IDs | |
| Secondary IDs | NO |
| Study ID_1 | |
| Org. issuing International ID_1 | |
| Study ID_2 | |
| Org. issuing International ID_2 | |
| IND to MHLW | |
| Institutions | |
| Institutions | |
| Other administrative information | |||||||
| Date of disclosure of the study information |
|
||||||
| Progress | |||||||
| Recruitment status | Preinitiation | ||||||
| Date of protocol fixation |
|
||||||
| Anticipated trial start date |
|
||||||
| Last follow-up date | |||||||
| Date of closure to data entry | |||||||
| Date trial data considered complete | |||||||
| Date analysis concluded | |||||||
| Related information | |
| URL releasing protocol | |
| Publication of results | Unpublished |
| URL releasing results | |
| Results | |
| Other related information | |
| Management information | |||||||
| Registered date |
|
||||||
| Last modified on |
|
||||||
| Link to view the page | |
| URL(English) | https://upload.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000030642 |